Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 25, 2025Cancer Immunology Research

Abstract PR-01: Targeting the ApoE-LDLR pathway disrupts MDSC-mediated systemic immunosuppression and enhances the efficacy of NK cell immunotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

XCXu ChaoHCHong‐Yuan ChenLCLiangjie Chi

Discussion

Loading...

Member takes

Overview

This study reveals that disrupting MDSC-mediated immunosuppression improves NK cell outcomes, suggesting new therapeutic targets.

Key Points

  • MDSC expansion significantly impairs both endogenous and adoptively transferred NK cell function in circulation and spleen.
  • Depletion of Gr-1+ MDSCs restored NK cell effector functions and improved anti-tumor responses in PDAC models.
  • Disrupting the ApoE-LDLR pathway in MDSCs reduced their immunosuppressive capacity on NK cells, showing potential as a therapeutic strategy.
  • Pharmacological inhibition of lipid utilization enhances NK cell function, suggesting a combinatorial approach for better immunotherapy outcomes.

Cite This Study

Chao et al. (2025) studied this question.

synapsesocial.com/papers/68d5d14eddad3c16d46369a0https://doi.org/10.1158/2326-6074.cimm25-pr-01
View Full Paper
Ask AI
Bookmark
Share